SUBFRACTIONAL SPECTRUM OF HIGH DENSITY LIPOPROTEIDS IN CORONARY ATHEROSCLEROSIS PATIENTS

Conclusion. A pattern of HDL dispersion, i.e. the higher relative amount of smaller dense particles of HDL and less amount of larger HDL is associated with coronary arteries lesion. Shift in subfractional spectrum of HDL to the side of potentially proatherogenic HDL particles can be found in patients even at earlier stages of atherosclerosis. 

1. Barter P. HDL-C: role as a risk modifier. Atheroscler Suppl. 2011; 12(3): 267-70.

2. Karol E. Watson, Beyond LDL-Cholesterol. The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy. J Manag Care Pharm 2008; 14(8-Suppl): S6-15.

3. Wijtske Annema, Arnold von Eckard. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J 2013; 77: 2432-48.

4. Krauss RM. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin lipidol 2010; 21(4): 305-11.

5. Rizzo M, Berneis K, Zeljkovic A, Vekic J. Should we routinely measure low-density and high-density lipoprotein subclasses? Clin Lab 2009; 55(11-12): 421-9.

6. Krychtiuk KA, Kastl SP, Pfaffenberger S, et al. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease. Atherosclerosis 2014; 237(2): 589-96.

7. deGoma EM, Rader DJ. High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein? JACC 2012; 60(6): 517-20.

8. Banuls C, Bellod L, Jover A, et al. Comparability of two different polyacrylamide gel electrophoresis methods for the classification of LDL pattern type. Clin Chim Acta 2012; 413(1-2): 251-7.

9. Oravec S, Dostal E, Dukát A, et al. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia. Neuro Endocrinol Lett 2011; 32(4): 502-9.

10. Xu RX, Guo YL, Li XL, et al. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype. Clin Exp Pharmacol Physiol 2014; 41(7): 475-81.

11. Utkina EA, Afanasyeva OI, Yezhov MV, et al. Association between different lipoprotein subfractions and coronary atherosclerosis in middle-aged men on statin therapy. Cardiovestnik 2014; 1: 68-76. Russian (Уткина Е.А., Афанасьева О.И., Ежов М.В. и др. Связь различных подфракций липопротеидов с коронарным атеро- склерозом у мужчин среднего возраста, получавших терапию статинами. Кардиологический вестник 2014; 1: 68-76).

12. Ozerova IN, Metelskaya VA, Perova NV, et al. Relationship of lipoprotein subfractions with triglycerides level in patients with of different grade of coronary atherosclerosis. Atherosclerosis and dislipidemias 2014; 2(15): 33-7. Russian (Озерова И.Н., Метельская В.А., Перова Н.В. и др. Связь субфракционного спектра липопротеинов низких плотностей с уровнем триглицеридов в крови при разной степени стенозов коронарных артерий. Атеросклероз и дислипидемии 2014; 2(15): 33-7).

13. Gavrilova NE, Metelskaya VA, Perova NV, et al. Selection for the quantitative evaluation method of coronary arteries based upon comparative analysis of angiographic scales. Russ J Cardiol 2014; 6(110): 24-9. Russian (Гаврилова Н.Е., Метельская В.А., Перова Н.В. и др. Выбор метода количественной оценки поражения коронарных артерий на основе сравнительного анализа ангиографических шкал. Российский кардиологический журнал 2014; 6(110): 24-9).

14. Brunzell JD, Zambon A, Deeb SS. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta 2012; 1821(3): 365-72.

15. Kannel WB, Vassan RS. Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol 2009; 24 (4): 345-50.